Clinical Trials Browser

Phase 2 × Advanced Biliary Tract Cancer × lenvatinib × Clear all

NCT05823987 2023-06-27

OPTIONS-05

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

NCT05781074 2023-03-24

CASTLE-08

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

NCT05410197 2022-10-12

Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer